ICU Medical (NASDAQ: ICUI) reported Q1 EPS of $1.81, $0.18 better than the analyst estimate of $1.63. Revenue for the quarter came in at $328.6 million versus the consensus estimate of $296.3 million.

Vivek Jain, ICU Medical’s Chief Executive Officer, said, “First quarter results were generally in line with our expectations except for some additional demand within our IV Solutions business due to the COVID-19 pandemic.”

GUIDANCE:

ICU Medical sees FY2020 EPS of $5.95-$6.65, versus prior of $6.50-$7.20 and the consensus of $6.87.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.